Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0777 for cognitive disability in schizophrenia
NCT00129441Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Aug 2005
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tpa-023 in schizophrenia, sponsored by University of Pittsburgh. Started Aug 2005; status: completed.
02
Drugs
tpa-023
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00129441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00129441.